Archives
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-06
- 2025-05
- 2025-04
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2018-07
-
CLK2 Inhibition to Overcome Platinum Resistance in Ovarian C
2026-07-28
This article reviews a recent study revealing that Cdc2-like kinase 2 (CLK2) drives platinum resistance in ovarian cancer by enhancing DNA repair via BRCA1 phosphorylation. The findings suggest targeting CLK2 as a promising strategy for improving chemotherapy response and inform future research on alternative splicing modulation and kinase inhibition.
-
Sex Differences in Angiotensin II-Induced Hypertension in Mi
2026-07-28
This study by Xue, Pamidimukkala, and Hay provides direct evidence that male and female mice differ significantly in their blood pressure response to chronic angiotensin II infusion. The findings highlight sex hormones’ influence on vascular regulation and baroreflex control, offering a robust model to study sex-specific mechanisms in hypertension.
-
Palonosetron Hydrochloride in Preventing Chemotherapy-Induce
2026-07-27
This article reviews the pivotal findings of Ruhlmann & Herrstedt’s study on palonosetron hydrochloride’s efficacy in preventing chemotherapy-induced nausea and vomiting (CINV). It explores how palonosetron’s unique pharmacological profile offers advantages over earlier 5-HT3 receptor antagonists, and discusses implications for antineoplastic chemotherapy regimens such as those using dacarbazine.
-
Psora 4: Precision Kv1.3 Blockade for T Cell Immunomodulatio
2026-07-27
Explore how Psora 4, a highly selective Kv1.3 blocker, advances immunology research by targeting effector memory T cell signaling with unparalleled specificity. This article delivers a mechanistic deep dive and practical insights, offering a unique perspective on Kv1.3 inhibition strategies.
-
Optimizing Cell Assays with EZ Cap™ Cy5 EGFP mRNA (5-moUTP)
2026-07-26
This evidence-based guide addresses real-world laboratory challenges in cell viability, proliferation, and cytotoxicity assays using EZ Cap™ Cy5 EGFP mRNA (5-moUTP) (SKU R1011). Drawing on recent biophysical insights and practical workflow considerations, it demonstrates how this dual-fluorescent, Cap 1-structured mRNA construct from APExBIO advances reproducibility, transfection quantification, and immune evasion in gene regulation studies.
-
H 89 2HCl: Selective PKA Inhibition in cAMP Signaling Resear
2026-07-25
H 89 2HCl is a potent, selective inhibitor of protein kinase A (PKA) used to dissect cAMP-dependent signaling. It exhibits sub-50 nM Ki for PKA, high selectivity over related kinases, and is widely validated in cell signaling workflows. This article details its mechanism, evidence, and best practices for experimental use.
-
NBC19: Targeting NLRP3 Inflammasomes in Tumor Microenvironme
2026-07-24
Explore how NBC19, a nanomolar NLRP3 inflammasome inhibitor, enables advanced investigation of inflammation and metastatic niche formation in cancer research. This in-depth guide reveals unique mechanistic insights and assay strategies, providing a new perspective beyond routine cytokine quantification.
-
Lopinavir (ABT-378): Optimizing HIV Protease and Antiviral A
2026-07-24
Lopinavir (ABT-378) stands out as a gold-standard HIV protease inhibitor, offering unmatched efficacy and serum stability for antiviral research. Explore workflow enhancements, cross-domain applications, and troubleshooting tips that empower robust experimental outcomes using APExBIO’s Lopinavir.
-
KR-12 Peptide Origami: Advances in Antimicrobial Engineering
2026-07-23
The reference review details the rational engineering and application of KR-12-derived antimicrobial peptides, focusing on their structural modifications, bioactivity, and potential for targeted delivery against drug-resistant pathogens. These findings offer new directions for combating persistent infections and inform strategies for improving antibiotic delivery and efficacy.
-
Firefly Luciferase mRNA (ARCA, 5-moUTP): Mechanism & Benchma
2026-07-23
Firefly Luciferase mRNA (ARCA, 5-moUTP) offers a robust, ARCA-capped, 5-methoxyuridine-modified platform for precise bioluminescent reporting in gene expression and cell viability assays. Its design maximizes mRNA stability, immune evasion, and translation efficiency, supporting sensitive in vitro and in vivo imaging applications. This article details the molecular rationale, mechanism, and validated performance metrics, referencing both peer-reviewed data and authoritative product documentation.
-
EdU Imaging Kits (488): Streamlined Cell Proliferation Assay
2026-07-22
EdU Imaging Kits (488) harness click chemistry to deliver rapid, high-fidelity S-phase DNA synthesis measurement—no harsh denaturation required. Optimized for both fluorescence microscopy and flow cytometry, these kits empower researchers to capture true cell proliferation dynamics in cancer and cell cycle studies.
-
A23187, Free Acid: Strategic Calcium Ionophore for Translati
2026-07-22
This thought-leadership article unpacks the mechanistic power and translational value of A23187, free acid—a benchmark calcium ionophore. By bridging detailed molecular insight with pragmatic experimental guidance, it empowers researchers to elevate the rigor and relevance of in vitro drug response assays. Drawing on primary literature, including Schwartz (2022) and curated expert resources, the article contextualizes A23187’s unique role in apoptosis, phosphoinositide signaling, and stress-response modeling. Strategic recommendations are provided for protocol optimization, alongside a critical assessment of the compound’s competitive landscape and limitations. The piece also connects to leading external resources, advancing the dialogue beyond conventional product pages and positioning APExBIO’s A23187, free acid as an essential tool for next-generation translational workflows.
-
Applied Native Protein Gel Electrophoresis: Optimal Use with
2026-07-21
The Basic Protein Native PAGE Gel Preparation and Electrophoresis Kit (PI ≤ 7.0) enables high-fidelity separation of acidic proteins while preserving native structure and function. Its robust, activity-preserving workflow accelerates research in protein identification, purification, and functional assays—especially where native conformation is crucial for downstream applications.
-
Indole-3-pyruvic Acid: Precision Workflows in Cell and Cance
2026-07-21
Indole-3-pyruvic acid (IPA) bridges plant hormone and immune modulation research, with recent breakthroughs revealing its role as an endogenous anti-cancer agent. This guide delivers actionable workflows and troubleshooting insights for harnessing IPA in both plant and mammalian experimental models, leveraging validated concentrations and real-world assay optimizations.
-
EdU Imaging Kits (488): Transforming S-Phase Proliferation A
2026-07-20
This thought-leadership article examines the mechanistic and strategic impact of EdU Imaging Kits (488) in translational research, bridging deep assay insight with actionable guidance. Drawing on reference studies and competitive landscape analysis, we explore how click chemistry-based DNA synthesis detection advances cell proliferation research for regenerative medicine and beyond.